Skip to Main Content

Paper Details

Harnessing synthetic lethality to predict the response to cancer treatment.
Nat Commun
72
2018
SL, SLi, cSLi, cancer, mouse, patient, patients, whole genome
Author NameAffiliation
Joshua J WaterfallNational Cancer Institute, National Institutes of Health
Joshua J WaterfallNational Cancer Institute, National Institutes of Health
Paul S MeltzerNational Cancer Institute, National Institutes of Health
Paul S MeltzerNational Cancer Institute, National Institutes of Health
Cyril H BenesMassachusetts General Hospital Center for Cancer Research
Cyril H BenesHarvard Medical School
Yardena SamuelsWeizmann Institute
Yardena SamuelsWeizmann Institute
Eytan RuppinCenter for Bioinformatics and Computational Biology, University of Maryland Institute of Advanced Computer Science (UMIACS) & Department of Computer Science, University of Maryland, College Park
Eytan RuppinNational Cancer Institute, National Institute of Health
Eytan RuppinTel Aviv University
Eytan RuppinThe Sackler School of Medicine, Tel Aviv University
  • 1 - 12

Datasets

Release 1.2